You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

estrogen receptor-beta agonist

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Overactive Bladder Syndrome Trial run by the (Vaginal estrogen, Mirabegron 50 MG [Myrbetriq])

Recruiting
  • Overactive Bladder Syndrome
  • Vaginal estrogen
  • Mirabegron 50 MG [Myrbetriq]
  • Bethesda, Maryland
    Walter Reed National Military Medical Center
Nov 3, 2022

Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Trial (Giredestrant, Fulvestrant, Abemaciclib)

Not yet recruiting
  • Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
  • (no location specified)
Sep 26, 2023

Breast Cancer Trial in Worldwide (GDC-9545, Palbociclib, LHRH Agonist)

Active, not recruiting
  • Breast Cancer
  • Aurora, Colorado
  • +23 more
Jan 30, 2023

Type 2 Diabetes, Obesity Trial in Sherbrooke (drug, other, diagnostic test, procedure)

Recruiting
  • Type 2 Diabetes
  • Obesity
  • Formoterol Fumarate 12 micrograms Inhalation Powder
  • +8 more
  • Sherbrooke, Quebec, Canada
    Centre de recherche du CHUS
Sep 22, 2022

Schizophrenia Trial in Indianapolis (LY500307 150mg, LY500307 75mg, Placebo)

Terminated
Has Results
  • Schizophrenia
  • LY500307 150mg
  • +3 more
  • Indianapolis, Indiana
  • +3 more
Jun 24, 2019

Breast Cancer Trial in Worldwide (GDC-0810, LHRH Agonist, Palbociclib)

Terminated
Has Results
  • Breast Cancer
  • San Diego, California
  • +13 more
May 25, 2021

Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma Trial in United States (Abemaciclib, Tamoxifen,

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +7 more
Aug 14, 2023

Locally Advanced or Metastatic Breast Cancer Trial in Worldwide (Phesgo, Giredestrant, Docetaxel)

Recruiting
  • Locally Advanced or Metastatic Breast Cancer
  • Los Angeles, California
  • +21 more
Jul 25, 2022

Hypertrophy, Left Ventricular Trial in Worldwide (drug, procedure, radiation)

Active, not recruiting
  • Hypertrophy, Left Ventricular
  • Brussels, Belgium
  • +8 more
Sep 28, 2021

Clomiphene Citrate asInhibitor of Ovulation inOocyte

Not yet recruiting
  • Infertility, Female
  • Infertility
  • Baton Rouge, Louisiana
    Womans Hospital
May 17, 2023

Breast Cancer. Real Clinical Practice in Russia

Recruiting
  • Breast Cancer
  • Neoadjuvant Endocrine Therapy
  • Tamoxifen 20mg
  • +4 more
  • Moscow, Russian Federation
    Blokhin's Russian Cancer Research Center
Apr 5, 2023

Type 1 Diabetes Trial in Uppsala (Liraglutide, Placebo for liraglutide)

Completed
  • Type 1 Diabetes
  • Uppsala, Sweden
    Uppsala University Hospital
Nov 4, 2020

Arterial Stiffness, White Matter Lesions, Cognitive Decline Trial in Atlanta, Winston-Salem, Pittsburgh (S-equol, Placebo)

Not yet recruiting
  • Arterial Stiffness
  • +2 more
  • Atlanta, Georgia
  • +2 more
Feb 13, 2023

Asthma Trial in United States (RPT193, Placebo)

Recruiting
  • Asthma
  • San Jose, California
  • +5 more
Jul 12, 2023

Urgency Urinary Incontinence Trial in United States (Beta3-Agonists, Adrenergic, OnabotulinumtoxinA 100 UNT [Botox])

Not yet recruiting
  • Urgency Urinary Incontinence
  • Beta3-Agonists, Adrenergic
  • OnabotulinumtoxinA 100 UNT [Botox]
  • Birmingham, Alabama
  • +4 more
Mar 28, 2023

Diabetes, Type 2 Trial in Amsterdam (device, drug, other)

Recruiting
  • Diabetes Mellitus, Type 2
  • ReCET
  • +2 more
  • Amsterdam, North-Holland, Netherlands
    Amsterdam UMC
Aug 9, 2023

Healthy Trial in Edmonton (Salbutamol 400mcg, Budesonide/formoterol, Placebo)

Recruiting
  • Healthy
  • Salbutamol 400mcg
  • +2 more
  • Edmonton, Alberta, Canada
    Clinical Physiology Laboratory
Sep 5, 2023

Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian

Not yet recruiting
  • Hormone-receptor-positive Breast Cancer
  • +3 more
  • Aromatase inhibitor
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Apr 5, 2023

Estrogen Receptor Positive, Recurrent Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7 Trial in Seattle (procedure, drug,

Terminated
Has Results
  • Estrogen Receptor Positive
  • +2 more
  • Computed Tomography
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 28, 2021

Breast Cancer Recurrent Trial in Worldwide (Palbociclib 125mg, Standard endocrine therapy)

Recruiting
  • Breast Cancer Recurrent
  • Palbociclib 125mg
  • Standard endocrine therapy
  • Graz, Austria
  • +52 more
Nov 15, 2022

Asthma Trial in Hackensack, New York (Fluticasone with salmeterol, Fluticasone HFA)

Completed
  • Asthma
  • Fluticasone with salmeterol
  • +3 more
  • Hackensack, New Jersey
  • +2 more
Oct 12, 2022

Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer Trial in Worldwide (Giredestrant,

Recruiting
  • Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
  • Anchorage, Alaska
  • +386 more
Jan 30, 2023

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Advanced Triple-Negative Breast Carcinoma
  • +4 more
  • Biopsy
  • +4 more
  • Birmingham, Alabama
  • +9 more
Aug 31, 2022

Urinary Incontinence, Urge, Urinary Incontinence, Overactive Bladder Trial in Palo Alto, San Francisco (Tolterodine Tartrate ER,

Recruiting
  • Urinary Incontinence, Urge
  • +5 more
  • Tolterodine Tartrate ER
  • +2 more
  • Palo Alto, California
  • +1 more
Dec 7, 2022

PCOS, ICSI Trial (dydrogesterone 20 mg /d (Duphaston, Abott Healthcare , Egypt), estradiol valerate 2 mg /d (white tablets of

Not yet recruiting
  • PCOS
  • ICSI
  • dydrogesterone 20 mg /d (Duphaston, Abott Healthcare , Egypt)
  • estradiol valerate 2 mg /d (white tablets of cycloprognova, Bayer Shering, Germany)
  • (no location specified)
Apr 12, 2022